Table 2 |
|||
|
Comparison of TRPC6 expression to tumour characteristics on 49 patients using χ2 analysis. |
|||
|
TRPC6 overexpression |
n |
X2 |
|
|
|
|||
|
LNM status |
|||
|
LNM |
78.3% |
23 |
|
|
no LNM |
69.2% |
26 |
0.4749 |
|
ER status |
|||
|
ER+ |
70.9% |
31 |
|
|
ER- |
81.8% |
11 |
0.5180 |
|
Tumor grade |
|||
|
1 |
73.3% |
15 |
|
|
2 |
68.4% |
19 |
0.4473 |
|
3 |
80% |
15 |
0.4473 |
|
|
|||
|
Absence of significant statistical correlation between TRPC6 overexpression and tumour characteristics (LNM: lymph node metastasis; ER: estrogen receptor). |
|||
|
Guilbert et al. BMC Cancer 2008 8:125 doi:10.1186/1471-2407-8-125 |
|||
